LGND Straddle Strategy
LGND (Ligand Pharmaceuticals Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration.
LGND (Ligand Pharmaceuticals Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.08B, a trailing P/E of 39.31, a beta of 1.04 versus the broader market, a 52-week range of 111.72-305.71, average daily share volume of 298K, a public-listing history dating back to 1992, approximately 68 full-time employees. These structural characteristics shape how LGND stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.04 places LGND roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 39.31 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a straddle on LGND?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current LGND snapshot
As of June 30, 2026, spot at $316.64, ATM IV 44.50%, IV rank 26.36%, expected move 12.76%. The straddle on LGND below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this straddle structure on LGND specifically: LGND IV at 44.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a LGND straddle, with a market-implied 1-standard-deviation move of approximately 12.76% (roughly $40.40 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LGND expiries trade a higher absolute premium for lower per-day decay. Position sizing on LGND should anchor to the underlying notional of $316.64 per share and to the trader's directional view on LGND stock.
LGND straddle setup
The LGND straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LGND near $316.64, the first option leg uses a $320.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LGND chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LGND shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $320.00 | $11.00 |
| Buy 1 | Put | $320.00 | $13.65 |
LGND straddle risk and reward
- Net Premium / Debit
- -$2,465.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$2,323.16
- Breakeven(s)
- $295.35, $344.65
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
LGND straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on LGND. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$29,534.00 |
| $70.02 | -77.9% | +$22,533.03 |
| $140.03 | -55.8% | +$15,532.05 |
| $210.04 | -33.7% | +$8,531.08 |
| $280.05 | -11.6% | +$1,530.10 |
| $350.06 | +10.6% | +$540.87 |
| $420.07 | +32.7% | +$7,541.85 |
| $490.08 | +54.8% | +$14,542.82 |
| $560.09 | +76.9% | +$21,543.80 |
| $630.10 | +99.0% | +$28,544.77 |
When traders use straddle on LGND
Straddles on LGND are pure-volatility plays that profit from large moves in either direction; traders typically buy LGND straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
LGND thesis for this straddle
The market-implied 1-standard-deviation range for LGND extends from approximately $276.24 on the downside to $357.04 on the upside. A LGND long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current LGND IV rank near 26.36% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LGND at 44.50%. As a Healthcare name, LGND options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LGND-specific events.
LGND straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LGND positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LGND alongside the broader basket even when LGND-specific fundamentals are unchanged. Always rebuild the position from current LGND chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on LGND?
- A straddle on LGND is the straddle strategy applied to LGND (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With LGND stock trading near $316.64, the strikes shown on this page are snapped to the nearest listed LGND chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LGND straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the LGND straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 44.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,323.16 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LGND straddle?
- The breakeven for the LGND straddle priced on this page is roughly $295.35 and $344.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LGND market-implied 1-standard-deviation expected move is approximately 12.76%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on LGND?
- Straddles on LGND are pure-volatility plays that profit from large moves in either direction; traders typically buy LGND straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current LGND implied volatility affect this straddle?
- LGND ATM IV is at 44.50% with IV rank near 26.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.